Bryostatin 1: differentiating agent from the depths.
Stone
R M
RM
Dana-Farber Cancer Institute, Division of Cancer Pharmacology, Boston, MA 02115, USA.
D000208:Acute Disease; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D054713:Bryostatins; D002454:Cell Differentiation / Q000187:drug effects*; D018922:HL-60 Cells; D006801:Humans; D007783:Lactones / Q000494:pharmacology* / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy; D018942:Macrolides; D009190:Myelodysplastic Syndromes / Q000188:drug therapy; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D054713:Bryostatins; D007783:Lactones; D018942:Macrolides; C046785:bryostatin 1